The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global AI Powered Cardiovascular Care Market Research Report 2025
Synopsis
AI powered cardiovascular care refers to the application of artificial intelligence (AI) technology in the field of cardiovascular medicine and healthcare. It involves using machine learning algorithms and computational models to analyze large volumes of cardiovascular data and provide advanced diagnostic, monitoring, and treatment solutions.
With AI-powered cardiovascular care, medical professionals and researchers can leverage algorithms to analyze patient data, including medical history, images, genetic profiles, and real-time physiological measurements, to make more accurate diagnoses, predict disease progression, and develop personalized treatment plans. AI algorithms can aid in early detection of cardiovascular conditions, risk assessment, and interpretation of complex medical images, such as echocardiograms or angiograms.
Additionally, AI-powered cardiovascular care can assist in monitoring patients remotely, using wearable devices and sensors to collect real-time physiological data and identify potential cardiac events or anomalies. It can enable proactive intervention and timely patient management, leading to improved outcomes and reduced healthcare costs. Overall, AI-powered cardiovascular care holds promise in enhancing precision medicine and optimizing cardiovascular healthcare delivery.
Global AI Powered Cardiovascular Care market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole AI Powered Cardiovascular Care market research.
Key companies engaged in the AI Powered Cardiovascular Care industry include IDOVEN, MAYO CLINIC, Aidoc, KenSci, Viz.AI, GE Healthcare, Powerful Medical, Novartis Pharmaceuticals and Apollo Hospitals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of AI Powered Cardiovascular Care were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole AI Powered Cardiovascular Care market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global AI Powered Cardiovascular Care market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
IDOVEN
MAYO CLINIC
Aidoc
KenSci
Viz.AI
GE Healthcare
Powerful Medical
Novartis Pharmaceuticals
Apollo Hospitals
Lark Health
Cardiologs
Arterys
Segment by Type
AI Powered Diagnosis
AI Powered Cardiovascular Imaging
AI Powered Treat
AI Powered Postoperative Monitoring
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The AI Powered Cardiovascular Care report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
AI powered cardiovascular care refers to the application of artificial intelligence (AI) technology in the field of cardiovascular medicine and healthcare. It involves using machine learning algorithms and computational models to analyze large volumes of cardiovascular data and provide advanced diagnostic, monitoring, and treatment solutions.
With AI-powered cardiovascular care, medical professionals and researchers can leverage algorithms to analyze patient data, including medical history, images, genetic profiles, and real-time physiological measurements, to make more accurate diagnoses, predict disease progression, and develop personalized treatment plans. AI algorithms can aid in early detection of cardiovascular conditions, risk assessment, and interpretation of complex medical images, such as echocardiograms or angiograms.
Additionally, AI-powered cardiovascular care can assist in monitoring patients remotely, using wearable devices and sensors to collect real-time physiological data and identify potential cardiac events or anomalies. It can enable proactive intervention and timely patient management, leading to improved outcomes and reduced healthcare costs. Overall, AI-powered cardiovascular care holds promise in enhancing precision medicine and optimizing cardiovascular healthcare delivery.
Global AI Powered Cardiovascular Care market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole AI Powered Cardiovascular Care market research.
Key companies engaged in the AI Powered Cardiovascular Care industry include IDOVEN, MAYO CLINIC, Aidoc, KenSci, Viz.AI, GE Healthcare, Powerful Medical, Novartis Pharmaceuticals and Apollo Hospitals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of AI Powered Cardiovascular Care were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole AI Powered Cardiovascular Care market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global AI Powered Cardiovascular Care market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
IDOVEN
MAYO CLINIC
Aidoc
KenSci
Viz.AI
GE Healthcare
Powerful Medical
Novartis Pharmaceuticals
Apollo Hospitals
Lark Health
Cardiologs
Arterys
Segment by Type
AI Powered Diagnosis
AI Powered Cardiovascular Imaging
AI Powered Treat
AI Powered Postoperative Monitoring
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The AI Powered Cardiovascular Care report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Powered Cardiovascular Care Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 AI Powered Diagnosis
1.2.3 AI Powered Cardiovascular Imaging
1.2.4 AI Powered Treat
1.2.5 AI Powered Postoperative Monitoring
1.2.6 Others
1.3 Market by Application
1.3.1 Global AI Powered Cardiovascular Care Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Powered Cardiovascular Care Market Perspective (2018-2029)
2.2 AI Powered Cardiovascular Care Growth Trends by Region
2.2.1 Global AI Powered Cardiovascular Care Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 AI Powered Cardiovascular Care Historic Market Size by Region (2018-2023)
2.2.3 AI Powered Cardiovascular Care Forecasted Market Size by Region (2024-2029)
2.3 AI Powered Cardiovascular Care Market Dynamics
2.3.1 AI Powered Cardiovascular Care Industry Trends
2.3.2 AI Powered Cardiovascular Care Market Drivers
2.3.3 AI Powered Cardiovascular Care Market Challenges
2.3.4 AI Powered Cardiovascular Care Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Powered Cardiovascular Care Players by Revenue
3.1.1 Global Top AI Powered Cardiovascular Care Players by Revenue (2018-2023)
3.1.2 Global AI Powered Cardiovascular Care Revenue Market Share by Players (2018-2023)
3.2 Global AI Powered Cardiovascular Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI Powered Cardiovascular Care Revenue
3.4 Global AI Powered Cardiovascular Care Market Concentration Ratio
3.4.1 Global AI Powered Cardiovascular Care Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Powered Cardiovascular Care Revenue in 2022
3.5 AI Powered Cardiovascular Care Key Players Head office and Area Served
3.6 Key Players AI Powered Cardiovascular Care Product Solution and Service
3.7 Date of Enter into AI Powered Cardiovascular Care Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Powered Cardiovascular Care Breakdown Data by Type
4.1 Global AI Powered Cardiovascular Care Historic Market Size by Type (2018-2023)
4.2 Global AI Powered Cardiovascular Care Forecasted Market Size by Type (2024-2029)
5 AI Powered Cardiovascular Care Breakdown Data by Application
5.1 Global AI Powered Cardiovascular Care Historic Market Size by Application (2018-2023)
5.2 Global AI Powered Cardiovascular Care Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America AI Powered Cardiovascular Care Market Size (2018-2029)
6.2 North America AI Powered Cardiovascular Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America AI Powered Cardiovascular Care Market Size by Country (2018-2023)
6.4 North America AI Powered Cardiovascular Care Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Powered Cardiovascular Care Market Size (2018-2029)
7.2 Europe AI Powered Cardiovascular Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe AI Powered Cardiovascular Care Market Size by Country (2018-2023)
7.4 Europe AI Powered Cardiovascular Care Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI Powered Cardiovascular Care Market Size (2018-2029)
8.2 Asia-Pacific AI Powered Cardiovascular Care Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific AI Powered Cardiovascular Care Market Size by Region (2018-2023)
8.4 Asia-Pacific AI Powered Cardiovascular Care Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI Powered Cardiovascular Care Market Size (2018-2029)
9.2 Latin America AI Powered Cardiovascular Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America AI Powered Cardiovascular Care Market Size by Country (2018-2023)
9.4 Latin America AI Powered Cardiovascular Care Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Powered Cardiovascular Care Market Size (2018-2029)
10.2 Middle East & Africa AI Powered Cardiovascular Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa AI Powered Cardiovascular Care Market Size by Country (2018-2023)
10.4 Middle East & Africa AI Powered Cardiovascular Care Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IDOVEN
11.1.1 IDOVEN Company Detail
11.1.2 IDOVEN Business Overview
11.1.3 IDOVEN AI Powered Cardiovascular Care Introduction
11.1.4 IDOVEN Revenue in AI Powered Cardiovascular Care Business (2018-2023)
11.1.5 IDOVEN Recent Development
11.2 MAYO CLINIC
11.2.1 MAYO CLINIC Company Detail
11.2.2 MAYO CLINIC Business Overview
11.2.3 MAYO CLINIC AI Powered Cardiovascular Care Introduction
11.2.4 MAYO CLINIC Revenue in AI Powered Cardiovascular Care Business (2018-2023)
11.2.5 MAYO CLINIC Recent Development
11.3 Aidoc
11.3.1 Aidoc Company Detail
11.3.2 Aidoc Business Overview
11.3.3 Aidoc AI Powered Cardiovascular Care Introduction
11.3.4 Aidoc Revenue in AI Powered Cardiovascular Care Business (2018-2023)
11.3.5 Aidoc Recent Development
11.4 KenSci
11.4.1 KenSci Company Detail
11.4.2 KenSci Business Overview
11.4.3 KenSci AI Powered Cardiovascular Care Introduction
11.4.4 KenSci Revenue in AI Powered Cardiovascular Care Business (2018-2023)
11.4.5 KenSci Recent Development
11.5 Viz.AI
11.5.1 Viz.AI Company Detail
11.5.2 Viz.AI Business Overview
11.5.3 Viz.AI AI Powered Cardiovascular Care Introduction
11.5.4 Viz.AI Revenue in AI Powered Cardiovascular Care Business (2018-2023)
11.5.5 Viz.AI Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Detail
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare AI Powered Cardiovascular Care Introduction
11.6.4 GE Healthcare Revenue in AI Powered Cardiovascular Care Business (2018-2023)
11.6.5 GE Healthcare Recent Development
11.7 Powerful Medical
11.7.1 Powerful Medical Company Detail
11.7.2 Powerful Medical Business Overview
11.7.3 Powerful Medical AI Powered Cardiovascular Care Introduction
11.7.4 Powerful Medical Revenue in AI Powered Cardiovascular Care Business (2018-2023)
11.7.5 Powerful Medical Recent Development
11.8 Novartis Pharmaceuticals
11.8.1 Novartis Pharmaceuticals Company Detail
11.8.2 Novartis Pharmaceuticals Business Overview
11.8.3 Novartis Pharmaceuticals AI Powered Cardiovascular Care Introduction
11.8.4 Novartis Pharmaceuticals Revenue in AI Powered Cardiovascular Care Business (2018-2023)
11.8.5 Novartis Pharmaceuticals Recent Development
11.9 Apollo Hospitals
11.9.1 Apollo Hospitals Company Detail
11.9.2 Apollo Hospitals Business Overview
11.9.3 Apollo Hospitals AI Powered Cardiovascular Care Introduction
11.9.4 Apollo Hospitals Revenue in AI Powered Cardiovascular Care Business (2018-2023)
11.9.5 Apollo Hospitals Recent Development
11.10 Lark Health
11.10.1 Lark Health Company Detail
11.10.2 Lark Health Business Overview
11.10.3 Lark Health AI Powered Cardiovascular Care Introduction
11.10.4 Lark Health Revenue in AI Powered Cardiovascular Care Business (2018-2023)
11.10.5 Lark Health Recent Development
11.11 Cardiologs
11.11.1 Cardiologs Company Detail
11.11.2 Cardiologs Business Overview
11.11.3 Cardiologs AI Powered Cardiovascular Care Introduction
11.11.4 Cardiologs Revenue in AI Powered Cardiovascular Care Business (2018-2023)
11.11.5 Cardiologs Recent Development
11.12 Arterys
11.12.1 Arterys Company Detail
11.12.2 Arterys Business Overview
11.12.3 Arterys AI Powered Cardiovascular Care Introduction
11.12.4 Arterys Revenue in AI Powered Cardiovascular Care Business (2018-2023)
11.12.5 Arterys Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
